| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
897 |
| issn |
1568-0266 |
| issueIdentifier |
8 |
| pageRange |
885-897 |
| publicationName |
Current Topics in Medicinal Chemistry |
| startingPage |
885 |
| bibliographicCitation |
Bickerdike MJ. 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Top Med Chem. 2003;3(8):885–97. doi: 10.2174/1568026033452249. PMID: 12678838. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e630630390dc2bf57319fd3a4257118 |
| date |
2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12678838
https://doi.org/10.2174/1568026033452249 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27009
https://portal.issn.org/resource/ISSN/1568-0266 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity |
| discusses |
http://id.nlm.nih.gov/mesh/M0018620
http://id.nlm.nih.gov/mesh/M0026371
http://id.nlm.nih.gov/mesh/M0239497 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D009765Q000188
http://id.nlm.nih.gov/mesh/D011985Q000187
http://id.nlm.nih.gov/mesh/D017366Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D011985Q000235
http://id.nlm.nih.gov/mesh/D018345
http://id.nlm.nih.gov/mesh/D015431
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D002149
http://id.nlm.nih.gov/mesh/D044405
http://id.nlm.nih.gov/mesh/D000818 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd8feabe317d8d0ada3199e40ec54f |